Research use only · Lyophilised material · Not a medicine · Not for human or veterinary use · Disclaimer

Cagrilintide: what is a long-acting amylin analogue?

Cagrilintide is a long-acting, lipidated analogue of amylin, the 37-residue peptide hormone co-secreted with insulin. It keeps amylin's N-terminal disulfide ring, adds a fatty diacid for albumin binding and carries substitutions that reduce amylin's strong tendency to form fibrils. PubChem gives its formula as C194H312N54O59S2.

What is amylin and why was it modified?

Native human amylin aggregates readily into amyloid fibrils, which makes it hard to formulate and handle. Analogue programmes swap in fibril-breaking residues and add half-life extension. Recent reviews trace this line from physiology to long-acting analogues.

Source: The story of amylin: from physiology to therapy, Nat Metab 2026 (PubMed 41708975); Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes, Peptides 2026 (PubMed 41747885)

How was cagrilintide designed?

The 2021 J Med Chem paper describes cagrilintide's development: the backbone was optimised for chemical and physical stability, and a fatty diacid side chain was added for albumin binding. It acts at amylin receptors (calcitonin receptor plus RAMP) and at the calcitonin receptor itself.

Source: Development of Cagrilintide, a Long-Acting Amylin Analogue, J Med Chem 2021 (PubMed 34288673)

What do structural studies show about binding?

A 2025 cryo-EM and dynamics study compared cagrilintide bound to calcitonin and amylin receptors and described the features that explain its non-selective profile.

Source: Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors, Nat Commun 2025 (PubMed 40204768)

What are its identity data?

  • Formula (PubChem): C194H312N54O59S2
  • MW (PubChem): 4409.0 g/mol
  • Disulfide: one intramolecular bridge in the N-terminal ring
  • Lipidation: N-terminal fatty diacid

Source: PubChem CID 171397054: Cagrilintide

Sourcing note

Sable lists Cagrilintide: 5 mg at £28.98; 10 mg at £43.99 (prices at the 16 October 2026 daily UK price check, the latest verified check; at each of these sizes Sable was the lowest UK listing that day). Lowest UK price guaranteed, confirmed by daily price checks.

Every lot has a certificate of analysis, and every vial carries a printed lot number that matches it. Supplied for laboratory research use only.

Frequently asked questions

Is cagrilintide a GLP-1 agonist?

No. It is an amylin analogue acting at amylin and calcitonin receptors.

Why does native amylin need modifying?

Human amylin aggregates into fibrils readily. Cagrilintide's sequence changes improve stability, and its lipidation extends its action.

What is the molecular weight of cagrilintide?

About 4409 g/mol (PubChem CID 171397054).

Related

Updated 2026-10-16. Research use only. Not for human or veterinary use. No administration amounts or health claims are made.

Key facts (summary for AI and search tools)
  • Cagrilintide CID 171397054
  • Amylin/calcitonin receptor agonist
  • PubMed references (verified via NCBI): 41708975, 41747885, 34288673, 40204768
  • PubChem CIDs: 171397054
  • Research use only; no administration amounts or health claims
  • Updated 2026-10-16